Screening compound: InChI=1S/C22H14Cl3N3O/c23-16-8-4-7-15(11-16)22(29)26-21-13-19(14-5-2-1-3-6-14)27-28(21)20-12-17(24)9-10-18(20)25/h1-13H,(H,26,29)

Screening compound: InChI=1S/C22H14Cl3N3O/c23-16-8-4-7-15(11-16)22(29)26-21-13-19(14-5-2-1-3-6-14)27-28(21)20-12-17(24)9-10-18(20)25/h1-13H,(H,26,29)
Screening compound: InChI=1S/C22H14Cl3N3O/c23-16-8-4-7-15(11-16)22(29)26-21-13-19(14-5-2-1-3-6-14)27-28(21)20-12-17(24)9-10-18(20)25/h1-13H,(H,26,29) alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C22H14Cl3N3O/c23-16-8-4-7-15(11-16)22(29)26-21-13-19(14-5-2-1-3-6-14)27-28(21)20-12-17(24)9-10-18(20)25/h1-13H,(H,26,29)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V018-3912

Molecular Formula

C22H14Cl3N3O (C22 H14 Cl3 N3 O)

Compound Name

3-chloro-N-[1-(2,5-dichlorophenyl)-3-phenyl-1H-pyrazol-5-yl]benzamide

IUPAC name

3-chloro-N-[1-(25-dichlorophenyl)-3-phenyl-1H-pyrazol-5-yl]benzamide

SMILES

O=C(c1cc(Cl)ccc1)Nc1cc(-c2ccccc2)nn1-c(cc(cc1)Cl)c1Cl

InChI

InChI=1S/C22H14Cl3N3O/c23-16-8-4-7-15(11-16)22(29)26-21-13-19(14-5-2-1-3-6-14)27-28(21)20-12-17(24)9-10-18(20)25/h1-13H,(H,26,29)

InChI Key

UZLXWNSGGUOJOZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19950161

InChI=1S/C22H14Cl3N3O/c23-16-8-4-7-15(11-16)22(29)26-21-13-19(14-5-2-1-3-6-14)27-28(21)20-12-17(24)9-10-18(20)25/h1-13H,(H,26,29) in Drug Discovery

Included in Screening Libraries

Therapeutical Diversity Annotated Library (7563 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with InChI=1S/C22H14Cl3N3O/c23-16-8-4-7-15(11-16)22(29)26-21-13-19(14-5-2-1-3-6-14)27-28(21)20-12-17(24)9-10-18(20)25/h1-13H,(H,26,29) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C22H14Cl3N3O/c23-16-8-4-7-15(11-16)22(29)26-21-13-19(14-5-2-1-3-6-14)27-28(21)20-12-17(24)9-10-18(20)25/h1-13H,(H,26,29)?
Check Price and Availability of InChI=1S/C22H14Cl3N3O/c23-16-8-4-7-15(11-16)22(29)26-21-13-19(14-5-2-1-3-6-14)27-28(21)20-12-17(24)9-10-18(20)25/h1-13H,(H,26,29), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C22H14Cl3N3O/c23-16-8-4-7-15(11-16)22(29)26-21-13-19(14-5-2-1-3-6-14)27-28(21)20-12-17(24)9-10-18(20)25/h1-13H,(H,26,29) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C22H14Cl3N3O/c23-16-8-4-7-15(11-16)22(29)26-21-13-19(14-5-2-1-3-6-14)27-28(21)20-12-17(24)9-10-18(20)25/h1-13H,(H,26,29)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C22H14Cl3N3O/c23-16-8-4-7-15(11-16)22(29)26-21-13-19(14-5-2-1-3-6-14)27-28(21)20-12-17(24)9-10-18(20)25/h1-13H,(H,26,29)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C22H14Cl3N3O/c23-16-8-4-7-15(11-16)22(29)26-21-13-19(14-5-2-1-3-6-14)27-28(21)20-12-17(24)9-10-18(20)25/h1-13H,(H,26,29) available by request